An observational study in Hypertension and Microalbuminuria, sponsored by Shanghai Zhongshan Hospital. Status unknown. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2018-07-26.
Sponsored by Shanghai Zhongshan Hospital · Observational
This study evaluates the effectiveness of different anti-hypertensive drugs on patients with hypertension and microalbuminuria.
This is a a real world registry study. All patients with hypertension in community hospitals in China will be eligible . Patient demographics, medical history, clinical characteristics, physical examination, laboratory tests (including UCAR, blood routine, urine routine, blood biochemistry, and ECG), antihypertensive drugs (including: ACEI/ ARB, thiazide diuretics, CCB, beta-blockers, alpha-blockers, and other antihypertensive drugs used in real-life clinical practice in other communities.) will be recorded. All patients are anticipated to be followed up for 12-month. Effectiveness of different antihypertensive medications on Urine Albumin-to-Creatinine Ratio (UACR) will be evaluted.
6,689 studies on the registry are indexed under Hypertension; 964 are open to participants now.
This study's planned enrollment of 3,000 is above the median of 210 across 1,358 observational studies indexed under Hypertension.
Browse Hypertension studies →Shanghai Zhongshan Hospital is the lead sponsor of 636 studies on the registry; 283 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Community Hypertensive Patients With Microalbuminuria
Exclusion Criteria:
Urine Albumin-to-Creatinine Ratio (UCAR)
Differences in UCAR between with ACEI/ARB and without ACEI/ARB
Time frame: 12 months
Combined endpoints: re-admission, cardiovascular events, and all-cause mortality
Differences in Combined endpoints between with ACEI/ARB and without ACEI/ARB
Time frame: 12 months
No study locations are listed for this record.
This study is status unknown, as verified in Jul 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Shanghai Zhongshan Hospital